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Preface to the Special Issue ‘Targeting Fish vaccination’ 
Fish farming in Aquaculture employs some 100,000 people and with an annual turnover of 7 
billion euros in Europe alone, is the world’s fastest growing industry within animal food 
production. However, the outcome can be severely affected by outbreaks of infectious diseases 
among the farmed fishes, not only costing the sector up to 20 % of its production value on 
average, but also having a significant impact on individual fish health and welfare, as well as on 
the environmental footprint of the industry, aspects which cannot be directly expressed in euros. 
When disease resistant fish are not available, the most appropriate method for controlling disease 
problems, both from a production and welfare point of view is often to vaccinate the fish in order 
to prevent these diseases from occurring in the first place. This is also in accordance with the 
EC-adapted strategy of prevention being better than cure in terms of husbandry animal health. 
The EU-funded TARGETFISH project (2012-2017) was thus set out to not only lay the 
fundamentals of how fish can establish an adequate memory response through vaccination able 
to confer them with a long term protection, but also to generate practically-relevant knowledge 
regarding, for example, safer and cheaper antigen formulations, novel types recombinant 
vaccines, different routes of vaccine administration suitable for mass vaccination or the 
development of adequate adjuvants. This special issue provides a glance of the diverse 
approaches taken within the project and provides interesting insights into a number of relevant 
issues fundamental to the success of fish vaccination. 
Specifically, this special issue includes fundamentally important issues such as the mechanisms 
of immunological memory (Yamaguchi et al.), essential for the duration of protection and 
underpinning the success of fish vaccination. Further related to vaccine induced immune 
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mechanisms, Granja and Tafalla studied the peritoneal responses of B cells in vaccinated fish, 
while Wangkahart, Secombes and Wang established the immune pathways involved in the 
response to a highly protective vaccination against ERM. 
Further, the use of (novel) adjuvants remains a continuing topic of interest (Galindo-Villegas et 
al.) for many antigenic formulations not able to provide a full protection on their own,  
exemplified  by the use of a non-mineral oil adjuvanted vaccine to induce a protective immune 
response against one of the most important bacteria causing disease in salmonid fish, namely 
Flavobacterium psychrophilum (Hoare et al.). Other studies specifically include attempts of 
vaccine delivery by oral route, not always successful but nonetheless (and maybe even more so) 
informative (Jaafar et al.; Embregts et al.). Along this line, the protection of antigens from 
degradation in the gastro-intestinal tract is an issue of importance when oral vaccination routes 
are preferred as addressed by Embregts et al. Often, different forms of antigen protection can 
indeed lead to a strong uptake of antigen and subsequent immune responses in the gut which, 
regretfully, are not always fully protective upon challenge. Yet, tailoring to individual diseases 
might be required, and better protection rates may be expected in the future when formulations, 
doses and distribution regimes of oral vaccines are optimized. Related to tailoring of vaccines 
against viral diseases studies of both protein and DNA based vaccines are included (Buonocore 
et al., Pascoli et al.; Embregts et al.; Sepulveda et al.). Recognizing that the latter type of 
recombinant vaccine, after having been used commercially for a decade in Canada, was recently 
approved by EMEA for protection of Atlantic salmon against pancreas disease and hereby 
becoming a practical reality also in Europe, a review of the history and perspectives of DNA 
based vaccines for aquacultured fish is also included (Collins, Lorenzen and Collet).   
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Last but not least, articles within this issue have focused on generic aspects related to vaccine 
development such as optimizing the sampling strategy during challenge trials (Hall, Collins and 
Collet) as well as identification of correlates of protective immunity following vaccination 
(Munang’anda and Evensen). These aspects have high practical relevance in terms of defining 
reliable read-outs of successful vaccines and vaccinations without use of large numbers of 
experimental animals. Currently, vaccine batch potency testing thus typically relies on 
vaccination-challenge trials comparing mortality in groups of vaccinated and control fish. 
While vaccination of aquacultured fishes has expanded very significantly since the early 
1980´ies, the most commonly used vaccines are still the traditional bacterin-based formulations 
for immersion or intraperitoneal delivery. However, these largely empirically-based vaccines are 
limited to a certain type of bacterial infections, and as illustrated by the papers in this issue and 
also exemplified by the new DNA vaccines, dedicated research combining both basic and 
applied aspects of fish immunology and vaccinology is needed to further explore the potential of 
disease prophylaxis by vaccination in the modern expanding aquaculture production. 
 
Geert F. Wiegertjes, Niels Lorenzen and Carolina Tafalla 
Editors of the Special Issue 
 
Preferred order of articles 
1. What could be the mechanisms of immunological memory in fish? 
https://www.sciencedirect.com/science/article/pii/S1050464818300354 
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2. Different IgM+ B cell subpopulations residing within the peritoneal cavity of vaccinated 
rainbow trout are differently regulated by BAFF 
https://www.sciencedirect.com/science/article/pii/S1050464817306034 
3. Dissecting the immune pathways stimulated following injection vaccination of rainbow 
trout (Oncorhynchus mykiss) against enteric redmouth disease (ERM) 
https://www.sciencedirect.com/science/article/pii/S1050464817304503 
4. Aluminum adjuvant potentiates gilthead seabream immune responses but induces toxicity 
in splenic melanomacrophage centers. 
https://www.sciencedirect.com/science/article/pii/S1050464818301153 
5. Efficacy and safety of a non-mineral oil adjuvanted injectable vaccine for the protection 
of Atlantic salmon (Salmo salar L.) against Flavobacterium psychrophilum 
https://www.sciencedirect.com/science/article/pii/S1050464817306058 
6. Pichia pastoris yeast as a vehicle for oral vaccination of larval and adult teleosts 
https://www.sciencedirect.com/science/article/pii/S1050464818304315 
7. Effect of oral booster vaccination of rainbow trout against Yersinia ruckeri depends on 
type of primary immunization 
https://www.sciencedirect.com/science/article/pii/S1050464817306563 
8. Vaccination of carp against SVCV with an oral-based vaccine or an insect cells-based 
subunit vaccine https://www.sciencedirect.com/science/article/pii/S1050464818301451 
9. VACCINATION AND IMMUNE RESPONSES OF EUROPEAN SEA BASS 
(Dicentrarchus labrax L.) AGAINST BETANODAVIRUS 
https://www.sciencedirect.com/science/article/pii/S1050464817307167 
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10. Lack of in vivo cross-protection of two different betanodavirus species RGNNV and 
SJNNV in European sea bass Dicentrachus labrax 
https://www.sciencedirect.com/science/article/pii/S105046481730640X 
11. Intra-muscular and oral vaccination using a Koi Herpesvirus ORF25 DNA vaccine does 
not confer protection 
https://www.sciencedirect.com/science/article/pii/S1050464818301530 
12. Time-course study of the immune protection induced by an interferon inducible DNA 
vaccine against viral haemorrhagic septicaemia in rainbow trout 
https://www.sciencedirect.com/science/article/pii/S1050464818303978 
13. DNA vaccination for the finfish aquaculture 
https://www.sciencedirect.com/science/article/pii/S1050464818304108 
14. The potential benefits of repeat sampling experiments for fish disease-challenge host-
pathogen investigations 
https://www.sciencedirect.com/science/article/pii/S1050464818300330 
15. Correlates of protective immunity for fish vaccines 
https://www.sciencedirect.com/science/article/pii/S1050464818301840 
